| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44015550 | HTLV-1 | ENSG00000203747.13 | protein_coding | FCGR3A | No | No | 2214 | P08637 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FCGR3A |
|---|---|
| DrugBank ID | DB00112 |
| Drug Name | Bevacizumab |
| Target ID | BE0002097 |
| UniProt ID | P08637 |
| Regulation Type | |
| PubMed IDs | 15886877 |
| Citations | Wang Y, Fei D, Vanderlaan M, Song A: Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro. Angiogenesis. 2004;7(4):335-45. doi: 10.1007/s10456-004-8272-2. Epub 2005 May 9. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | Bevacizumab Action Pathway |
| PharmGKB | PA130232992 |
| ChEMBL | CHEMBL1201583 |
